VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies

Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery

(2013) X. Liu et al.   CURRENT MEDICINAL CHEMISTRY

Drug discovery enters a new era with multi-target intervention strategy

(2012) Xiao-ying Tian et al.   Chinese Journal of Integrative Medicine

Use of genome-wide association studies for drug repositioning

(2012) Philippe Sanseau et al.   NATURE BIOTECHNOLOGY

Drug repositioning for Alzheimer's disease

(2012) Anne Corbett et al.   NATURE REVIEWS DRUG DISCOVERY

ChemProt-2.0: visual navigation in a disease chemical biology database

(2012) Sonny Kim Kjærulff et al.   NUCLEIC ACIDS RESEARCH

Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer

(2012) Daichi Shigemizu et al.   PLoS Computational Biology

Molecular approaches to personalizing management of ovarian cancer

(2011) R. C. Bast   ANNALS OF ONCOLOGY

Signatures for drug repositioning

(2011) Charlotte Harrison   NATURE REVIEWS GENETICS

KEGG for integration and interpretation of large-scale molecular data sets

(2011) M. Kanehisa et al.   NUCLEIC ACIDS RESEARCH

Network properties of human disease genes with pleiotropic effects

(2010) Sreenivas Chavali et al.   BMC Systems Biology

Network medicine: a network-based approach to human disease

(2010) Albert-László Barabási et al.   NATURE REVIEWS GENETICS

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs

(2010) C. Knox et al.   NUCLEIC ACIDS RESEARCH

VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology

(2009) Zhenjun Hu et al.   NUCLEIC ACIDS RESEARCH

VisANT: an integrative framework for networks in systems biology

(2008) Z. Hu et al.   BRIEFINGS IN BIOINFORMATICS

Network pharmacology: the next paradigm in drug discovery

(2008) Andrew L Hopkins   Nature Chemical Biology